Skip to content

A Prospective Observational Comparison of SMP and ESWL for the Treatment of Renal Stones ≥20 mm in Children (IAU-04)

A Prospective Observational Comparison of Super-mini Percutaneous Nephrolithotomy (SMP) and Extracorporeal Shock Wave Lithotripsy (ESWL) for the Treatment of Renal Stones ≥20 mm in Children: An IAU Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04317443
Enrollment
250
Registered
2020-03-23
Start date
2020-05-01
Completion date
2021-09-01
Last updated
2020-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone

Keywords

percutaneous nephrolithotomy, pcnl, miniperc, smp, children

Brief summary

ESWL and PNL are the two treatment modalities for kidney stones greater than 20 mm in the pediatric population. ESWL is non-invasive, does not require anesthesia and inexpensive, but its success rate may be lower, and require multiple treatment sessions. On the contrary, PNL has a higher success rate, does not require multiple sessions but is an invasive method. Compared to standard PNL, miniaturized PNL systems have been shown to decrease complications with comparable success rates. SMP is a unique miniaturized PNL system with integrated active irrigation and suction systems. The current literature lacks studies comparing SMP and ESWL prospectively in the pediatric population. In this study, the effectiveness, reliability, and reusability of ESWL and SMP will be compared.

Detailed description

To compare the success and complication rates of super-mini-percutaneous nephrolithotomy (SMP) and Extracorporeal Shock Wave Lithotripsy (ESWL) for the treatment of renal stones ≥20 mm in children.An international multicentre, prospective, observational study. Pediatric cases with renal Stones ≥20 mm who undergo ESWL or SMP will be evaluated and compared proespectively. The total number of departments planned to be included in the study is 10 and the number of cases is 180.

Interventions

PROCEDURESuper-mini percutaneous nephrolithotomy (SMP)

SMP will be performed under general anesthesia in prone/supine position. Renal puncture will be performed under ultrasound/fluoroscopy guidance based on the preference of the participating surgeon. Tracts will be dilated to 14 Fr. Stone fragmentation will be performed with holmium laser and fragments will be extracted with the active suction system. For the exit strategy, placement of a nephrostomy tube or JJ stent will be decided by the participating surgeon.

ESWL will be performed under sedation/analgesia, shock wave lithotripsy parameters will be determined based on the device and the settings of local center. For patients requiring multiple sessions, maximum 3 (or more) sessions will be allowed. Ureteral stenting prior to ESWL will be performed based on the decision of the participating center.

Sponsors

The International Alliance of Urolithiasis
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* Children ≤14 years old with renal Stones ≥20 mm * Willing and able to sign informed consent * Normal renal function * No stone-related surgical history * American Society of Anesthesiology (ASA) score 1-2

Exclusion criteria

* Congenital renal anomalies (horseshoe kidney, ureteropelvic junction obstruction) * Uncorrected UTI * Abnormal coagulation function * Morbid obese children (BMI≥35)

Design outcomes

Primary

MeasureTime frameDescription
Stone free rate3-monthsStone clearance on the computed tomography (2mm thickness)

Secondary

MeasureTime frameDescription
blood lossPostoperative day 1Number of participants requiring blood transfusion after the procedure
auxiliary proceduresPostoperative month 3Number of patients requiring additional auxiliary procedures such as second look PCNL, SWL, Ureteroscopy
hospital stayPostoperative month 3From date of admission until the date of discharge,length of hospital stay
complicationsPostoperative month 3Rate of postoperative complications using the Clavien-Dindo system

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026